Press Room

2022 CPhI Worldwide

Start
Tuesday, November 01, 2022 - 09:00
End
Thursday, November 03, 2022 - 09:00
Location: Frankfurt, Germany
Booth Number: 90F41 - 90F51
Schedule a meeting with Hovione at CPhI worldwide, booth nr. 90F41 - 90F51 | Hovione

 

Join Hovione at CPhI Worldwide and meet the team in whose attentive hands you can place your project.

 

Schedule a meeting button | Hovione

 

 

We look forward to seeing you at CPhI Worldwide

to present the most reliable and innovative end-to-end solutions to help your project succeed.

 

Also interested:

The Future is Continuous

Meet our experts and find out if
Continuous Tableting is right for your product​​​​​

 

The Leader in Spray Drying

Contact our experts to overcome your
solubility issues with the best scale-up science

 

Dispersome® 

Learn more about the innovative technology
capable of solving the poor solubility issues of your drug candidate
 

ASD-Hipros 

Meet our experts to identify the best performing
and stable formulations for your drug
 

Everything for Inhalation

Meet our experts to bring your
Inhaled medicine to patients
 

The Specialist Integrated CDMO

Contact our experts to take your project
to market faster​​​
 

​​​​​​

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025